Privia Health Group (PRVA) Financials

$22.55 -0.52 (-2.25%)

Closing price 05/29/2025 04:00 PM Eastern

Extended Trading

$22.55 0.00 (0.00%)

As of 05/29/2025 05:21 PM Eastern

Annual Income Statements for Privia Health Group

This table shows Privia Health Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	14	23	-8.59	-188	31	8.24
Consolidated Net Income / (Loss)	17	21	-12	-191	31	7.95
Net Income / (Loss) Continuing Operations	17	21	-12	-191	31	7.95
Total Pre-Tax Income	28	29	-19	-219	23	9.15
Total Operating Income	17	21	-19	-217	25	16
Total Gross Profit	1,509	1,460	1,186	791	712	691
Total Revenue	1,736	1,658	1,357	966	817	786
Operating Revenue	1,736	1,658	1,357	966	817	786
Total Cost of Revenue	227	198	171	175	105	95
Operating Cost of Revenue	227	198	171	175	105	95
Total Operating Expenses	1,492	1,439	1,205	1,009	687	675
Selling, General & Admin Expense	126	110	130	256	44	42
Marketing Expense	26	25	20	23	11	9.16
Depreciation Expense	7.27	6.53	4.57	2.46	1.84	1.43
Other Operating Expenses / (Income)	1,333	1,299	1,051	728	629	623
Total Other Income / (Expense), net	11	8.37	0.54	-1.07	-1.92	-6.91
Other Income / (Expense), net	11	8.37	0.54	-	-	-
Income Tax Expense	11	7.99	-6.52	-28	-7.44	1.21
Net Income / (Loss) Attributable to Noncontrolling Interest	2.66	-2.05	-3.48	-2.42	-0.34	-0.30
Basic Earnings per Share	$0.12	$0.20	($0.08)	($1.83)	$0.33	$0.09
Weighted Average Basic Shares Outstanding	119.40M	116.73M	110.70M	102.95M	95.95M	95.93M
Diluted Earnings per Share	$0.11	$0.19	($0.08)	($1.83)	$0.33	$0.09
Weighted Average Diluted Shares Outstanding	125.61M	124.69M	110.70M	102.95M	95.95M	95.93M
Weighted Average Basic & Diluted Shares Outstanding	120.51M	118.57M	115.00M	108.17M	-	-

This table shows Privia Health Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	4.22	4.40	3.54	3.47	2.98	2.84	5.64	7.27	7.32	18	1.62
Consolidated Net Income / (Loss)	6.05	5.37	3.98	4.64	3.06	2.32	5.94	6.36	6.40	17	0.56
Net Income / (Loss) Continuing Operations	6.05	5.37	3.98	4.64	3.06	2.32	5.94	6.36	6.40	17	0.56
Total Pre-Tax Income	8.15	8.02	7.98	8.06	3.81	4.27	8.43	7.80	8.53	3.40	-4.29
Total Operating Income	5.22	5.25	5.81	5.10	0.82	1.42	5.54	6.98	6.71	2.25	-4.57
Total Gross Profit	421	401	382	365	361	388	367	363	342	321	299
Total Revenue	480	461	438	422	415	441	417	413	386	364	343
Operating Revenue	480	461	438	422	415	441	417	413	386	364	343
Total Cost of Revenue	60	60	56	57	54	52	50	50	45	43	44
Operating Cost of Revenue	60	60	56	57	54	52	50	50	45	43	44
Total Operating Expenses	415	396	376	360	360	387	361	356	335	319	304
Selling, General & Admin Expense	32	34	31	29	32	30	27	27	26	28	32
Marketing Expense	6.92	6.46	7.05	6.85	6.09	6.25	7.24	5.96	5.29	5.17	5.09
Depreciation Expense	1.90	1.83	1.80	1.82	1.82	1.77	1.73	1.69	1.34	1.14	1.15
Other Operating Expenses / (Income)	375	353	337	323	320	349	325	322	302	284	265
Total Other Income / (Expense), net	2.93	2.77	2.16	2.97	2.98	2.85	2.89	0.82	1.81	1.15	0.29
Other Income / (Expense), net	2.93	-	2.16	2.97	-	-	2.89	0.82	-	-	-
Income Tax Expense	2.10	2.66	4.00	3.42	0.75	1.94	2.49	1.44	2.13	-13	-4.85
Net Income / (Loss) Attributable to Noncontrolling Interest	1.83	0.97	0.44	1.18	0.07	-0.51	0.30	-0.91	-0.92	-0.93	-1.07
Basic Earnings per Share	$0.03	$0.03	$0.03	$0.03	$0.03	$0.03	$0.05	$0.06	$0.06	$0.17	$0.01
Weighted Average Basic Shares Outstanding	120.62M	119.40M	119.66M	119.30M	118.51M	116.73M	117.60M	116.16M	115.01M	110.70M	111.59M
Diluted Earnings per Share	$0.03	$0.03	$0.03	$0.03	$0.02	$0.02	$0.05	$0.06	$0.06	$0.17	$0.01
Weighted Average Diluted Shares Outstanding	127.75M	125.61M	125.75M	125.32M	125.05M	124.69M	124.92M	124.57M	124.33M	110.70M	124.85M
Weighted Average Basic & Diluted Shares Outstanding	121.92M	120.51M	120.00M	119.56M	119.32M	118.57M	118.06M	117.36M	115.66M	115.00M	114.30M

This table details how cash moves in and out of Privia Health Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	102	42	27	236	38	7.78
Net Cash From Operating Activities	109	81	47	55	39	24
Net Cash From Continuing Operating Activities	109	81	47	55	39	24
Net Income / (Loss) Continuing Operations	17	21	-12	-191	31	7.95
Consolidated Net Income / (Loss)	17	21	-12	-191	31	7.95
Depreciation Expense	1.10	1.17	1.22	1.15	1.19	0.78
Amortization Expense	6.16	5.36	4.04	1.47	0.78	0.98
Non-Cash Adjustments To Reconcile Net Income	57	37	67	267	0.48	0.21
Changes in Operating Assets and Liabilities, net	28	16	-13	-24	5.54	14
Net Cash From Investing Activities	-12	-43	-0.10	-33	-0.38	-5.71
Net Cash From Continuing Investing Activities	-12	-43	-0.10	-33	-0.38	-5.71
Acquisitions	-6.96	-43	0.00	-32	0.00	0.00
Other Investing Activities, net	-5.02	-0.11	-0.10	-	-	-
Net Cash From Financing Activities	4.33	3.71	-20	214	-0.77	-11
Net Cash From Continuing Financing Activities	4.33	3.71	-20	214	-0.77	-11
Repayment of Debt	0.00	0.00	-33	-1.16	-11	-46
Payment of Dividends	0.00	-5.69	0.00	0.00	-	-
Issuance of Common Equity	1.65	0.66	0.13	224	0.00	0.00
Other Financing Activities, net	2.68	8.74	13	3.83	0.11	0.00
Cash Interest Paid	0.29	0.04	0.71	0.89	1.93	9.20
Cash Income Taxes Paid	3.76	1.04	0.31	0.50	0.38	0.32

This table details how cash moves in and out of Privia Health Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-22	69	35	36	-38	59	12	6.72	-37	31	25
Net Cash From Operating Activities	-24	75	33	34	-33	64	22	7.61	-13	29	16
Net Cash From Continuing Operating Activities	-24	75	33	34	-33	64	22	7.61	-13	29	16
Net Income / (Loss) Continuing Operations	6.05	5.37	3.98	4.64	3.06	2.32	5.94	6.36	6.40	17	0.56
Consolidated Net Income / (Loss)	6.05	5.37	3.98	4.64	3.06	2.32	5.94	6.36	6.40	17	0.56
Depreciation Expense	0.23	0.23	0.29	0.29	0.29	0.30	0.30	0.29	0.29	0.29	0.31
Amortization Expense	1.67	1.60	1.51	1.53	1.53	1.48	1.43	1.40	1.05	0.84	0.84
Non-Cash Adjustments To Reconcile Net Income	18	15	15	14	12	14	8.29	9.94	4.69	9.18	15
Changes in Operating Assets and Liabilities, net	-50	52	12	14	-50	46	6.50	-10	-26	2.00	-0.40
Net Cash From Investing Activities	0.00	-6.27	-	-	-5.71	-5.02	-13	-0.07	-25	-0.02	-0.02
Net Cash From Continuing Investing Activities	0.00	-6.27	-	-	-5.71	-5.02	-13	-0.07	-25	-0.02	-0.02
Acquisitions	0.00	-6.25	-	-	-0.71	-5.00	-13	-	-25	-	-
Other Investing Activities, net	0.00	-0.02	-	-	-5.01	-0.02	-0.02	-0.07	0.00	-	-
Net Cash From Financing Activities	2.24	0.62	1.49	1.75	0.48	0.04	3.01	-0.82	1.48	1.96	8.57
Net Cash From Continuing Financing Activities	2.24	0.62	1.49	1.75	0.48	0.04	3.01	-0.82	1.48	1.96	8.57
Other Financing Activities, net	2.24	0.62	0.84	0.75	0.48	-0.05	3.01	4.31	1.48	1.96	8.57
Cash Interest Paid	0.00	0.06	0.07	0.06	0.09	-	-0.02	0.04	0.02	0.03	0.03
Cash Income Taxes Paid	-0.31	0.23	0.64	3.11	-0.23	0.02	0.42	0.60	-0.01	0.04	0.02

This table presents Privia Health Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	1,136	1,000	793	686	329
Total Current Assets	835	701	552	447	190
Cash & Equivalents	491	390	348	321	85
Accounts Receivable	316	291	190	117	99
Prepaid Expenses	27	21	14	8.70	6.33
Plant, Property, & Equipment, net	1.24	2.33	3.39	4.50	4.81
Total Noncurrent Assets	300	297	237	235	134
Goodwill	142	139	127	128	119
Intangible Assets	110	108	57	60	5.98
Noncurrent Deferred & Refundable Income Taxes	26	35	40	33	4.95
Other Noncurrent Operating Assets	22	15	13	14	4.48
Total Liabilities & Shareholders' Equity	1,136	1,000	793	686	329
Total Liabilities	452	393	274	236	185
Total Current Liabilities	449	387	264	190	147
Accounts Payable	82	58	53	46	39
Other Current Liabilities	367	329	211	144	107
Total Noncurrent Liabilities	3.19	5.56	9.49	46	38
Other Noncurrent Operating Liabilities	3.19	5.56	9.49	14	5.60
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	683	607	519	450	144
Total Preferred & Common Equity	635	561	499	427	147
Total Common Equity	635	561	499	427	147
Common Stock	814	755	716	635	167
Retained Earnings	-179	-194	-217	-208	-20
Noncontrolling Interest	48	46	20	23	-3.10

This table presents Privia Health Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,184	1,146	1,078	1,032	992	938	875	808
Total Current Assets	886	854	780	728	698	654	589	580
Cash & Equivalents	469	422	387	351	330	318	311	317
Accounts Receivable	389	409	370	346	350	320	261	246
Prepaid Expenses	28	23	22	31	17	16	17	16
Plant, Property, & Equipment, net	1.01	1.46	1.75	2.04	2.60	2.88	3.10	3.66
Total Noncurrent Assets	296	290	296	301	292	281	283	224
Goodwill	142	139	139	139	136	135	135	127
Intangible Assets	108	103	105	106	107	96	98	58
Noncurrent Deferred & Refundable Income Taxes	25	28	31	34	35	37	39	27
Other Noncurrent Operating Assets	22	20	21	22	14	12	12	12
Total Liabilities & Shareholders' Equity	1,184	1,146	1,078	1,032	992	938	875	808
Total Liabilities	474	483	434	409	401	366	319	317
Total Current Liabilities	471	479	430	404	394	358	310	305
Accounts Payable	68	66	61	51	54	49	46	47
Other Current Liabilities	403	414	369	353	340	310	263	257
Total Noncurrent Liabilities	3.20	3.91	4.42	4.96	7.08	7.82	9.13	12
Other Noncurrent Operating Liabilities	3.20	3.91	4.42	4.96	7.08	7.82	9.13	12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	710	662	644	623	591	571	557	491
Total Preferred & Common Equity	659	615	595	577	545	525	513	470
Total Common Equity	659	615	595	577	545	525	513	470
Common Stock	834	799	783	767	741	727	723	705
Retained Earnings	-175	-184	-187	-191	-196	-202	-209	-234
Noncontrolling Interest	50	47	48	46	46	46	43	21

This table displays calculated financial ratios and metrics derived from Privia Health Group's official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	4.74%	22.19%	40.41%	18.25%	3.91%	0.00%
EBITDA Growth	-1.17%	366.88%	93.80%	-885.60%	53.44%	0.00%
EBIT Growth	-3.97%	256.19%	91.46%	-956.72%	58.01%	0.00%
NOPAT Growth	-30.59%	211.78%	91.21%	-555.31%	139.74%	0.00%
Net Income Growth	-18.95%	274.30%	93.67%	-716.91%	288.97%	0.00%
EPS Growth	-42.11%	337.50%	95.63%	-654.55%	266.67%	0.00%
Operating Cash Flow Growth	35.28%	71.17%	-14.28%	41.57%	59.66%	0.00%
Free Cash Flow Firm Growth	212.89%	-43.02%	89.95%	-274.17%	0.00%	0.00%
Invested Capital Growth	-11.74%	27.37%	5.48%	74.98%	0.00%	0.00%
Revenue Q/Q Growth	1.17%	4.83%	7.03%	6.81%	0.00%	0.00%
EBITDA Q/Q Growth	72.57%	29.88%	62.42%	-11.90%	0.00%	0.00%
EBIT Q/Q Growth	111.87%	35.12%	54.37%	-12.12%	0.00%	0.00%
NOPAT Q/Q Growth	35.99%	-44.83%	53.04%	-12.12%	0.00%	0.00%
Net Income Q/Q Growth	21.73%	-40.85%	70.43%	-8.95%	0.00%	0.00%
EPS Q/Q Growth	10.00%	-44.12%	78.38%	-9.58%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	10.85%	76.24%	724.82%	-14.02%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	27.91%	46.34%	82.50%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-19.94%	-16.41%	-1.79%	115.01%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	86.93%	88.08%	87.41%	81.92%	87.15%	87.89%
EBITDA Margin	2.02%	2.14%	-0.98%	-22.23%	3.35%	2.27%
Operating Margin	0.98%	1.25%	-1.41%	-22.50%	3.11%	2.04%
EBIT Margin	1.61%	1.75%	-1.37%	-22.50%	3.11%	2.04%
Profit (Net Income) Margin	0.98%	1.27%	-0.89%	-19.73%	3.78%	1.01%
Tax Burden Percent	61.16%	72.46%	64.93%	87.25%	131.71%	86.81%
Interest Burden Percent	100.00%	100.00%	100.00%	100.49%	92.45%	56.98%
Effective Tax Rate	38.84%	27.54%	0.00%	0.00%	-31.71%	13.19%
Return on Invested Capital (ROIC)	5.06%	7.69%	-8.03%	-119.45%	72.14%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	3.55%	6.05%	-8.45%	-96.77%	82.05%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-2.42%	-3.96%	5.54%	55.24%	-29.11%	0.00%
Return on Equity (ROE)	2.64%	3.73%	-2.49%	-64.21%	43.03%	0.00%
Cash Return on Invested Capital (CROIC)	17.54%	-16.38%	-13.37%	-173.98%	-127.86%	0.00%
Operating Return on Assets (OROA)	2.61%	3.24%	-2.51%	-42.83%	7.72%	0.00%
Return on Assets (ROA)	1.60%	2.35%	-1.63%	-37.55%	9.39%	0.00%
Return on Common Equity (ROCE)	2.45%	3.52%	-2.38%	-62.02%	43.95%	0.00%
Return on Equity Simple (ROE_SIMPLE)	2.68%	3.75%	-2.42%	-44.66%	21.06%	0.00%
Net Operating Profit after Tax (NOPAT)	10	15	-13	-152	33	14
NOPAT Margin	0.60%	0.90%	-0.99%	-15.75%	4.09%	1.77%
Net Nonoperating Expense Percent (NNEP)	1.51%	1.65%	0.42%	-22.68%	-9.91%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.52%	2.46%	-2.58%	-	-	-
Cost of Revenue to Revenue	13.07%	11.92%	12.59%	18.08%	12.85%	12.11%
SG&A Expenses to Revenue	7.27%	6.61%	9.55%	26.48%	5.39%	5.32%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	85.95%	86.83%	88.82%	104.42%	84.04%	85.84%
Earnings before Interest and Taxes (EBIT)	28	29	-19	-217	25	16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	35	36	-13	-215	27	18
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	3.69	4.84	5.20	6.45	3.06	0.00
Price to Tangible Book Value (P/TBV)	6.11	8.63	8.25	11.52	20.29	0.00
Price to Revenue (P/Rev)	1.35	1.64	1.91	2.85	0.55	0.57
Price to Earnings (P/E)	163.09	117.81	0.00	0.00	14.35	54.40
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.61%	0.85%	0.00%	0.00%	6.97%	1.84%
Enterprise Value to Invested Capital (EV/IC)	9.90	10.90	13.26	15.36	4.26	0.00
Enterprise Value to Revenue (EV/Rev)	1.10	1.43	1.67	2.58	0.48	0.00
Enterprise Value to EBITDA (EV/EBITDA)	54.16	66.81	0.00	0.00	14.42	0.00
Enterprise Value to EBIT (EV/EBIT)	68.29	81.85	0.00	0.00	15.54	0.00
Enterprise Value to NOPAT (EV/NOPAT)	183.25	158.77	0.00	0.00	11.80	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.42	29.40	48.05	45.23	10.14	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	52.92	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.07	0.23	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.07	0.23	0.00
Financial Leverage	-0.68	-0.65	-0.66	-0.57	-0.35	0.00
Leverage Ratio	1.65	1.59	1.53	1.71	2.29	0.00
Compound Leverage Factor	1.65	1.59	1.53	1.72	2.12	0.00
Debt to Total Capital	0.00%	0.00%	0.00%	6.75%	18.98%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.18%	0.49%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	6.56%	18.49%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.06%	7.57%	3.84%	4.83%	-1.75%	0.00%
Common Equity to Total Capital	92.94%	92.43%	96.16%	88.43%	82.76%	0.00%
Debt to EBITDA	0.00	0.00	0.00	-0.15	1.23	0.00
Net Debt to EBITDA	0.00	0.00	0.00	1.34	-1.86	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	-0.15	1.20	0.00
Debt to NOPAT	0.00	0.00	0.00	-0.21	1.01	0.00
Net Debt to NOPAT	0.00	0.00	0.00	1.89	-1.52	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	-0.21	0.98	0.00
Altman Z-Score	4.91	6.02	7.38	7.38	4.26	0.00
Noncontrolling Interest Sharing Ratio	7.30%	5.85%	4.46%	3.40%	-2.16%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.86	1.81	2.09	2.35	1.29	0.00
Quick Ratio	1.80	1.76	2.03	2.30	1.25	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	36	-32	-22	-222	-59	0.00
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	10,065.45%	10,234.47%	426.66%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-207.19	-30.91	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	51.46	20.29	3.53
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	50.94	20.09	2.70
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	1.63	1.85	1.83	1.90	2.48	0.00
Accounts Receivable Turnover	5.72	6.90	8.84	8.93	8.24	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	973.59	580.54	343.98	207.43	169.73	0.00
Accounts Payable Turnover	3.25	3.57	3.46	4.10	2.68	0.00
Days Sales Outstanding (DSO)	63.79	52.88	41.30	40.90	44.28	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	112.41	102.18	105.57	89.03	136.44	0.00
Cash Conversion Cycle (CCC)	-48.62	-49.29	-64.27	-48.13	-92.16	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	192	218	171	162	93	0.00
Invested Capital Turnover	8.47	8.52	8.14	7.58	17.63	0.00
Increase / (Decrease) in Invested Capital	-26	47	8.89	69	93	0.00
Enterprise Value (EV)	1,903	2,375	2,268	2,490	394	0.00
Market Capitalization	2,346	2,719	2,596	2,755	449	449
Book Value per Share	$5.29	$4.76	$4.37	$4.01	$1.53	$0.00
Tangible Book Value per Share	$3.20	$2.67	$2.75	$2.25	$0.23	$0.00
Total Capital	683	607	519	483	177	0.00
Total Debt	0.00	0.00	0.00	33	34	0.00
Total Long-Term Debt	0.00	0.00	0.00	32	33	0.00
Net Debt	-491	-390	-348	-288	-51	0.00
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.55	0.38	5.71
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-105	-76	-60	-63	-41	0.00
Debt-free Net Working Capital (DFNWC)	386	314	288	257	44	0.00
Net Working Capital (NWC)	386	314	288	256	43	0.00
Net Nonoperating Expense (NNE)	-6.66	-6.07	-1.32	38	2.52	6.00
Net Nonoperating Obligations (NNO)	-491	-390	-348	-288	-51	0.00
Total Depreciation and Amortization (D&A)	7.27	6.53	5.26	2.62	1.96	1.76
Debt-free, Cash-free Net Working Capital to Revenue	-6.07%	-4.56%	-4.45%	-6.57%	-4.97%	0.00%
Debt-free Net Working Capital to Revenue	22.21%	18.93%	21.21%	26.61%	5.39%	0.00%
Net Working Capital to Revenue	22.21%	18.93%	21.21%	26.52%	5.28%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.12	$0.20	($0.08)	($1.83)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	119.40M	116.73M	110.70M	102.95M	0.00	0.00
Adjusted Diluted Earnings per Share	$0.11	$0.19	($0.08)	($1.83)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	125.61M	124.69M	110.70M	102.95M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	120.51M	118.57M	115.00M	108.17M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	10	15	-13	-152	18	14
Normalized NOPAT Margin	0.60%	0.90%	-0.99%	-15.75%	2.17%	1.77%
Pre Tax Income Margin	1.61%	1.75%	-1.37%	-22.61%	2.87%	1.16%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-203.21	13.24	2.32
NOPAT to Interest Expense	0.00	0.00	0.00	-142.25	17.44	2.02
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-203.72	13.04	1.50
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-142.76	17.24	1.19
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	27.08%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	27.08%	0.00%	-6.66%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Privia Health Group's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.62%	4.55%	4.95%	2.17%	7.50%	20.97%	21.69%	23.19%	23.10%	32.36%	36.33%
EBITDA Growth	78.57%	121.80%	-3.81%	4.17%	-67.17%	-5.67%	397.02%	376.08%	177.51%	118.60%	72.18%
EBIT Growth	114.05%	269.58%	-5.37%	3.44%	-87.74%	-36.86%	284.30%	248.50%	158.15%	111.62%	64.29%
NOPAT Growth	486.00%	354.09%	-25.71%	-48.45%	-86.89%	-93.06%	221.87%	254.92%	162.36%	182.27%	64.29%
Net Income Growth	97.84%	130.94%	-33.05%	-27.00%	-52.26%	-86.21%	968.71%	155.88%	135.40%	241.71%	105.11%
EPS Growth	50.00%	50.00%	-40.00%	-50.00%	-66.67%	-88.24%	400.00%	160.00%	137.50%	241.67%	111.11%
Operating Cash Flow Growth	27.39%	16.69%	47.61%	353.10%	-147.59%	119.87%	39.12%	5.40%	-151.58%	336.64%	-74.23%
Free Cash Flow Firm Growth	237.42%	163.18%	128.31%	100.06%	60.95%	-2,145.50%	18.99%	-30.71%	19.26%	102.71%	-20.81%
Invested Capital Growth	-11.59%	-11.74%	-7.86%	1.14%	10.76%	27.37%	49.66%	44.85%	40.69%	5.48%	130.93%
Revenue Q/Q Growth	4.17%	5.25%	3.69%	1.71%	-5.80%	5.64%	0.95%	7.01%	6.00%	6.28%	2.19%
EBITDA Q/Q Growth	41.95%	-27.56%	-1.09%	273.75%	-17.17%	-68.59%	7.12%	17.78%	138.00%	198.92%	0.44%
EBIT Q/Q Growth	55.28%	-34.21%	-1.08%	879.83%	-42.04%	-83.16%	8.13%	16.12%	198.53%	149.17%	12.88%
NOPAT Q/Q Growth	10.26%	21.12%	-1.24%	344.30%	-14.56%	-80.18%	-31.46%	12.95%	-54.76%	447.97%	12.88%
Net Income Q/Q Growth	12.65%	34.92%	-14.32%	51.93%	31.50%	-60.89%	-6.57%	-0.66%	-62.00%	2,930.22%	104.89%
EPS Q/Q Growth	0.00%	0.00%	0.00%	50.00%	0.00%	-60.00%	-16.67%	0.00%	-64.71%	1,600.00%	110.00%
Operating Cash Flow Q/Q Growth	-132.17%	125.61%	-3.81%	204.01%	-151.70%	185.39%	195.27%	156.84%	-145.91%	80.58%	123.71%
Free Cash Flow Firm Q/Q Growth	21.56%	24.43%	52,712.42%	100.17%	44.11%	44.25%	-13.52%	-10.41%	-3,027.27%	102.21%	-83.16%
Invested Capital Q/Q Growth	24.91%	-19.94%	-6.27%	-5.68%	24.70%	-16.41%	2.88%	3.29%	43.40%	-1.79%	-0.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	87.60%	87.03%	87.20%	86.48%	86.98%	88.11%	87.94%	87.86%	88.42%	88.11%	87.22%
EBITDA Margin	2.09%	1.54%	2.23%	2.34%	0.64%	0.72%	2.44%	2.29%	2.09%	0.93%	-1.00%
Operating Margin	1.09%	1.14%	1.33%	1.21%	0.20%	0.32%	1.33%	1.69%	1.74%	0.62%	-1.33%
EBIT Margin	1.70%	1.14%	1.82%	1.91%	0.20%	0.32%	2.02%	1.89%	1.74%	0.62%	-1.33%
Profit (Net Income) Margin	1.26%	1.16%	0.91%	1.10%	0.74%	0.53%	1.42%	1.54%	1.66%	4.62%	0.16%
Tax Burden Percent	74.19%	66.90%	49.87%	57.58%	80.27%	54.45%	70.49%	81.58%	75.08%	495.38%	-12.96%
Interest Burden Percent	100.00%	152.86%	100.00%	100.00%	462.58%	300.56%	100.00%	100.00%	127.00%	151.22%	93.77%
Effective Tax Rate	25.81%	33.10%	50.13%	42.42%	19.73%	45.55%	29.51%	18.42%	24.92%	-395.38%	0.00%
Return on Invested Capital (ROIC)	5.68%	6.45%	4.54%	4.63%	1.04%	1.50%	6.80%	9.69%	8.89%	24.89%	-9.48%
ROIC Less NNEP Spread (ROIC-NNEP)	5.15%	6.03%	4.25%	4.14%	0.31%	1.07%	6.17%	9.47%	8.43%	23.10%	-10.65%
Return on Net Nonoperating Assets (RNNOA)	-3.17%	-4.11%	-2.55%	-2.40%	-0.18%	-0.70%	-3.69%	-5.57%	-4.94%	-15.16%	7.68%
Return on Equity (ROE)	2.51%	2.34%	1.99%	2.22%	0.86%	0.79%	3.11%	4.13%	3.95%	9.74%	-1.80%
Cash Return on Invested Capital (CROIC)	17.50%	17.54%	11.23%	2.15%	-6.06%	-16.38%	-27.31%	-26.26%	-36.76%	-13.37%	-101.97%
Operating Return on Assets (OROA)	2.76%	1.85%	2.92%	3.21%	0.35%	0.60%	3.55%	3.38%	3.11%	1.13%	-2.35%
Return on Assets (ROA)	2.05%	1.89%	1.46%	1.85%	1.30%	0.98%	2.50%	2.76%	2.96%	8.48%	0.29%
Return on Common Equity (ROCE)	2.33%	2.17%	1.84%	2.05%	0.80%	0.75%	2.92%	3.86%	3.69%	9.30%	-1.77%
Return on Equity Simple (ROE_SIMPLE)	3.04%	0.00%	2.28%	2.68%	3.07%	0.00%	6.53%	5.74%	2.42%	0.00%	-8.68%
Net Operating Profit after Tax (NOPAT)	3.87	3.51	2.90	2.94	0.66	0.77	3.90	5.69	5.04	11	-3.20
NOPAT Margin	0.81%	0.76%	0.66%	0.70%	0.16%	0.18%	0.94%	1.38%	1.31%	3.06%	-0.93%
Net Nonoperating Expense Percent (NNEP)	0.53%	0.42%	0.29%	0.48%	0.72%	0.42%	0.63%	0.22%	0.46%	1.79%	1.16%
Return On Investment Capital (ROIC_SIMPLE)	0.55%	0.51%	-	-	-	0.13%	-	-	-	2.15%	-
Cost of Revenue to Revenue	12.40%	12.97%	12.80%	13.52%	13.02%	11.89%	12.06%	12.14%	11.58%	11.89%	12.78%
SG&A Expenses to Revenue	6.61%	7.47%	7.01%	6.85%	7.74%	6.71%	6.53%	6.49%	6.72%	7.73%	9.40%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	86.51%	85.89%	85.87%	85.27%	86.78%	87.79%	86.61%	86.17%	86.68%	87.49%	88.55%
Earnings before Interest and Taxes (EBIT)	8.15	5.25	7.98	8.06	0.82	1.42	8.43	7.80	6.71	2.25	-4.57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	10	7.08	9.77	9.88	2.64	3.19	10	9.49	8.05	3.38	-3.42
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.10	3.69	3.54	3.48	4.01	4.84	4.96	5.75	6.19	5.20	8.06
Price to Tangible Book Value (P/TBV)	6.60	6.11	5.85	5.90	6.98	8.63	8.94	10.27	11.32	8.25	13.30
Price to Revenue (P/Rev)	1.50	1.35	1.27	1.22	1.37	1.64	1.71	2.00	2.22	1.91	2.99
Price to Earnings (P/E)	173.20	163.09	169.78	138.88	123.43	117.81	71.00	88.83	195.40	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.58%	0.61%	0.59%	0.72%	0.81%	0.85%	1.41%	1.13%	0.51%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	9.52	9.90	7.51	6.77	7.39	10.90	9.27	10.85	11.85	13.26	20.07
Enterprise Value to Revenue (EV/Rev)	1.27	1.10	1.05	1.02	1.19	1.43	1.53	1.82	2.03	1.67	2.76
Enterprise Value to EBITDA (EV/EBITDA)	57.79	54.16	88.53	86.65	92.22	66.81	88.23	164.69	634.60	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	70.98	68.29	137.04	134.70	136.05	81.85	112.46	241.74	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	171.96	183.25	236.04	207.30	186.97	158.77	89.06	123.69	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	19.32	17.42	18.28	19.74	32.90	29.40	52.69	69.53	74.29	48.05	610.93
Enterprise Value to Free Cash Flow (EV/FCFF)	51.05	52.92	64.11	316.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.62	-0.68	-0.60	-0.58	-0.56	-0.65	-0.60	-0.59	-0.59	-0.66	-0.72
Leverage Ratio	1.66	1.65	1.71	1.66	1.62	1.59	1.66	1.62	1.58	1.53	1.61
Compound Leverage Factor	1.66	2.53	1.71	1.66	7.48	4.78	1.66	1.62	2.00	2.31	1.51
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.06%	7.06%	7.14%	7.49%	7.39%	7.57%	7.85%	8.07%	7.77%	3.84%	4.25%
Common Equity to Total Capital	92.94%	92.94%	92.86%	92.51%	92.61%	92.43%	92.15%	91.93%	92.23%	96.16%	95.75%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.18	4.84	4.39	4.61	5.15	5.92	5.75	6.66	7.68	7.46	8.74
Noncontrolling Interest Sharing Ratio	7.21%	7.30%	7.47%	7.76%	7.57%	5.85%	6.22%	6.55%	6.52%	4.46%	1.71%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.88	1.86	1.78	1.81	1.80	1.81	1.77	1.82	1.90	2.09	1.90
Quick Ratio	1.82	1.80	1.73	1.76	1.73	1.76	1.73	1.78	1.85	2.03	1.85
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	35	29	23	0.04	-26	-46	-83	-73	-66	2.25	-102
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	100,906.25%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.63	1.63	1.61	1.68	1.77	1.85	1.76	1.79	1.79	1.83	1.76
Accounts Receivable Turnover	4.90	5.72	4.52	4.92	5.56	6.90	5.30	5.65	6.69	8.84	7.35
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1,180.37	973.59	846.94	733.58	657.20	580.54	505.22	440.95	390.26	343.98	316.73
Accounts Payable Turnover	3.91	3.25	3.66	3.90	4.27	3.57	3.71	4.08	3.85	3.46	6.78
Days Sales Outstanding (DSO)	74.45	63.79	80.71	74.25	65.67	52.88	68.84	64.64	54.54	41.30	49.63
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	93.25	112.41	99.68	93.59	85.48	102.18	98.30	89.39	94.80	105.57	53.85
Cash Conversion Cycle (CCC)	-18.80	-48.62	-18.97	-19.34	-19.81	-49.29	-29.46	-24.76	-40.26	-64.27	-4.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	240	192	240	256	272	218	261	253	245	171	174
Invested Capital Turnover	7.04	8.47	6.85	6.65	6.53	8.52	7.27	7.04	6.81	8.14	10.16
Increase / (Decrease) in Invested Capital	-31	-26	-20	2.89	26	47	86	78	71	8.89	99
Enterprise Value (EV)	2,286	1,903	1,803	1,735	2,008	2,375	2,415	2,748	2,907	2,268	3,496
Market Capitalization	2,706	2,346	2,177	2,074	2,313	2,719	2,699	3,020	3,175	2,596	3,792
Book Value per Share	$5.47	$5.29	$5.14	$4.99	$4.87	$4.76	$4.64	$4.54	$4.46	$4.37	$4.22
Tangible Book Value per Share	$3.40	$3.20	$3.11	$2.94	$2.80	$2.67	$2.57	$2.54	$2.44	$2.75	$2.56
Total Capital	710	683	662	644	623	607	591	571	557	519	491
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-469	-491	-422	-387	-351	-390	-330	-318	-311	-348	-317
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-54	-105	-48	-37	-27	-76	-27	-22	-32	-60	-42
Debt-free Net Working Capital (DFNWC)	416	386	374	350	324	314	303	296	279	288	275
Net Working Capital (NWC)	416	386	374	350	324	314	303	296	279	288	275
Net Nonoperating Expense (NNE)	-2.17	-1.86	-1.08	-1.71	-2.40	-1.55	-2.04	-0.67	-1.36	-5.71	-3.76
Net Nonoperating Obligations (NNO)	-469	-491	-422	-387	-351	-390	-330	-318	-311	-348	-317
Total Depreciation and Amortization (D&A)	1.90	1.83	1.80	1.82	1.82	1.77	1.73	1.69	1.34	1.14	1.15
Debt-free, Cash-free Net Working Capital to Revenue	-2.98%	-6.07%	-2.78%	-2.20%	-1.59%	-4.56%	-1.70%	-1.49%	-2.25%	-4.45%	-3.30%
Debt-free Net Working Capital to Revenue	23.08%	22.21%	21.81%	20.65%	19.23%	18.93%	19.19%	19.61%	19.53%	21.21%	21.70%
Net Working Capital to Revenue	23.08%	22.21%	21.81%	20.65%	19.23%	18.93%	19.19%	19.61%	19.53%	21.21%	21.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.03	$0.03	$0.03	$0.03	$0.03	$0.03	$0.05	$0.06	$0.06	$0.17	$0.01
Adjusted Weighted Average Basic Shares Outstanding	120.62M	119.40M	119.66M	119.30M	118.51M	116.73M	117.60M	116.16M	115.01M	110.70M	111.59M
Adjusted Diluted Earnings per Share	$0.03	$0.03	$0.03	$0.03	$0.02	$0.02	$0.05	$0.06	$0.06	$0.17	$0.01
Adjusted Weighted Average Diluted Shares Outstanding	127.75M	125.61M	125.75M	125.32M	125.05M	124.69M	124.92M	124.57M	124.33M	110.70M	124.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	121.92M	120.51M	120.00M	119.56M	119.32M	118.57M	118.06M	117.36M	115.66M	115.00M	114.30M
Normalized Net Operating Profit after Tax (NOPAT)	3.87	3.51	4.07	2.94	0.66	0.77	3.90	5.69	5.04	1.57	-3.20
Normalized NOPAT Margin	0.81%	0.76%	0.93%	0.70%	0.16%	0.18%	0.94%	1.38%	1.31%	0.43%	-0.93%
Pre Tax Income Margin	1.70%	1.74%	1.82%	1.91%	0.92%	0.97%	2.02%	1.89%	2.21%	0.93%	-1.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	27.08%	16.02%	18.88%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	27.08%	16.02%	18.88%	0.00%	0.00%	0.00%

Frequently Asked Questions About Privia Health Group's Financials

When does Privia Health Group's financial year end?

According to the most recent income statement we have on file, Privia Health Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Privia Health Group's net income changed over the last 5 years?

Privia Health Group's net income appears to be on a downward trend, with a most recent value of $17.04 million in 2024, rising from $7.95 million in 2019. The previous period was $21.03 million in 2023. See where experts think Privia Health Group is headed by visiting Privia Health Group's forecast page.

What is Privia Health Group's operating income?

Privia Health Group's total operating income in 2024 was $16.98 million, based on the following breakdown:

Total Gross Profit: $1.51 billion
Total Operating Expenses: $1.49 billion

How has Privia Health Group revenue changed over the last 5 years?

Over the last 5 years, Privia Health Group's total revenue changed from $786.36 million in 2019 to $1.74 billion in 2024, a change of 120.8%.

How much debt does Privia Health Group have?

Privia Health Group's total liabilities were at $452.34 million at the end of 2024, a 15.2% increase from 2023, and a 144.1% increase since 2020.

How much cash does Privia Health Group have?

In the past 4 years, Privia Health Group's cash and equivalents has ranged from $84.63 million in 2020 to $491.15 million in 2024, and is currently $491.15 million as of their latest financial filing in 2024.

How has Privia Health Group's book value per share changed over the last 5 years?

Over the last 5 years, Privia Health Group's book value per share changed from 0.00 in 2019 to 5.29 in 2024, a change of 529.3%.

Related Companies

This page (NASDAQ:PRVA) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Financials

Frequently Asked Questions About Privia Health Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Financials

Annual Income Statements for Privia Health Group

Quarterly Income Statements for Privia Health Group

Annual Cash Flow Statements for Privia Health Group

Quarterly Cash Flow Statements for Privia Health Group

Annual Balance Sheets for Privia Health Group

Quarterly Balance Sheets for Privia Health Group

Annual Metrics And Ratios for Privia Health Group

Quarterly Metrics And Ratios for Privia Health Group

Frequently Asked Questions About Privia Health Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools